Preclinical differentiation of low molecular weight heparins.
Publication
, Journal Article
Nader, HB; Walenga, JM; Berkowitz, SD; Ofosu, F; Hoppensteadt, DA; Cella, G
Published in: Semin Thromb Hemost
1999
Duke Scholars
Published In
Semin Thromb Hemost
ISSN
0094-6176
Publication Date
1999
Volume
25 Suppl 3
Start / End Page
63 / 72
Location
United States
Related Subject Headings
- Thrombin
- Structure-Activity Relationship
- Prothrombin
- Humans
- Heparin, Low-Molecular-Weight
- Factor Xa Inhibitors
- Cardiovascular System & Hematology
- Biological Availability
- Animals
- 3201 Cardiovascular medicine and haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Nader, H. B., Walenga, J. M., Berkowitz, S. D., Ofosu, F., Hoppensteadt, D. A., & Cella, G. (1999). Preclinical differentiation of low molecular weight heparins. Semin Thromb Hemost, 25 Suppl 3, 63–72.
Nader, H. B., J. M. Walenga, S. D. Berkowitz, F. Ofosu, D. A. Hoppensteadt, and G. Cella. “Preclinical differentiation of low molecular weight heparins.” Semin Thromb Hemost 25 Suppl 3 (1999): 63–72.
Nader HB, Walenga JM, Berkowitz SD, Ofosu F, Hoppensteadt DA, Cella G. Preclinical differentiation of low molecular weight heparins. Semin Thromb Hemost. 1999;25 Suppl 3:63–72.
Nader, H. B., et al. “Preclinical differentiation of low molecular weight heparins.” Semin Thromb Hemost, vol. 25 Suppl 3, 1999, pp. 63–72.
Nader HB, Walenga JM, Berkowitz SD, Ofosu F, Hoppensteadt DA, Cella G. Preclinical differentiation of low molecular weight heparins. Semin Thromb Hemost. 1999;25 Suppl 3:63–72.
Published In
Semin Thromb Hemost
ISSN
0094-6176
Publication Date
1999
Volume
25 Suppl 3
Start / End Page
63 / 72
Location
United States
Related Subject Headings
- Thrombin
- Structure-Activity Relationship
- Prothrombin
- Humans
- Heparin, Low-Molecular-Weight
- Factor Xa Inhibitors
- Cardiovascular System & Hematology
- Biological Availability
- Animals
- 3201 Cardiovascular medicine and haematology